Skip to content

Insider · CIK 0001842114

Gwendolyn Gresham

officer

Files at CLB (Core Laboratories Inc. /DE/). First filing -, latest -.

In brief

Gwendolyn Gresham files SEC Form 4 as officer at CLB (Core Laboratories Inc. /DE/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Gwendolyn Gresham has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 12, 2026CLB
Core Laboratories Inc. /DE/
AGrant or award
Performance Sharesderivative
+33,490$0.00$033,490Feb 17, 2026
Dec 31, 2025CLB
Core Laboratories Inc. /DE/
FTax withholding
Common Stock
-19,301$16.03$309k33,226Jan 5, 2026
Dec 31, 2025CLB
Core Laboratories Inc. /DE/
MOption exercise
Common Stock
+24,952$0.00$052,527Jan 5, 2026
Dec 31, 2025CLB
Core Laboratories Inc. /DE/
MOption exercise
Performance Sharesderivative
-24,952$0.00$00Jan 5, 2026
Feb 13, 2025CLB
Core Laboratories Inc. /DE/
AGrant or award
Performance Sharesderivative
+32,912$0.00$032,912Feb 13, 2025
Dec 31, 2024CLB
Core Laboratories Inc. /DE/
FTax withholding
Common Stock
-5,989$17.31$104k27,575Jan 3, 2025
Dec 31, 2024CLB
Core Laboratories Inc. /DE/
MOption exercise
Common Stock
+9,604$0.00$033,564Jan 3, 2025
Dec 31, 2024CLB
Core Laboratories Inc. /DE/
MOption exercise
Performance Sharesderivative
-9,604$0.00$00Jan 3, 2025

Questions about Gwendolyn Gresham

Answered from the filings on this page, as of the latest one.

Is Gwendolyn Gresham buying or selling?

Gwendolyn Gresham has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Gwendolyn Gresham's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gwendolyn Gresham has 0.

Where does Gwendolyn Gresham file Form 4?

Gwendolyn Gresham has filed Form 4 at CLB (Core Laboratories Inc. /DE/) as SVP. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Gwendolyn Gresham: insider trades and track record | InsiderTell